| ID | Name | CAS | Properties |
logPoct/wat |
| 62-766-3 |
2,4-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 8.617 |
| 62-808-6 |
5-«alpha»-Pregnan-20-«beta»-ol-3,11-dione, MO-TMS
|
|
2 | 6.500 |
| 62-824-8 |
Triazolo[4,5-d]pyrimidine, 1h-v-, 5-amino-7-ethoxy-
|
91314-05-5 |
2 | -0.753 |
| 62-872-5 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether (isomer 2)
|
|
2 | 2.928 |
| 62-908-5 |
D-Selenomethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 2.249 |
| 62-988-7 |
5.alpha.-Pregnane-11,20-dione-3.alpha.,21-diol, MO-TMS, # 2
|
|
2 | 6.941 |
| 63-019-1 |
Phthalimide, n-[(2(3h)-oxo-3-phenyl-3-benzofuranyl)methyl]-
|
|
2 | 3.188 |
| 63-036-2 |
Methyl chol-4,6-dien-3-one-24-oate, oxime, TMS
|
|
2 | 7.138 |
| 63-055-1 |
4-Butyl-1-phenylpyrazolidine-3,5-diol, O,O'-bis(trimethylsilyl ether
|
|
2 | 5.642 |
| 63-083-0 |
Silanamine, N-[2-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-N,1,1,1-tetramethyl-2-[(trimethylsilyl)oxy]ethyl]-
|
56114-63-7 |
2 | 5.568 |
| 63-188-4 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTBDMSi, (17-O)-TMSi
|
|
2 | 11.420 |
| 63-231-5 |
2-Hydroxybut-2-enedioic acid, O-trimethylsilyl-, bis(trimethylsilyl) ester
|
|
2 | 3.478 |
| 63-250-4 |
5«alpha»-Androst-1-ene-3«beta»,17«alpha»-diol, per-TMS
|
|
2 | 7.245 |
| 63-252-2 |
[13C] 16«alpha», 17-H2-16, 17-(OH)2-GA4 methyl ester TMS ether
|
|
2 | 5.969 |
| 63-377-4 |
5-«beta»-Pregnan-3-«beta»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 7.718 |
| 63-455-7 |
[1,2,5] Thiadiazolo[3,4-d]pyrimidine-5,7-bis (2-hydroxyethylamino)-
|
|
2 | -0.710 |
| 63-487-2 |
4-P-tolylsulfonylhydrazo-6-methyl-1,3,3a,7-tetrazaindene
|
109445-77-4 |
2 | 1.047 |
| 63-514-1 |
O,O'-Bis(tert-butyldimethylsilyl) ,2-trimethylsilylamino-9-(2-hydroxyethoxymethyl)-purin-6-ol ether
|
|
2 | 4.112 |
| 63-541-1 |
13,14-Dihydro-6,15-diketo-PGF1A, EO-TMS, isomer # 1
|
|
2 | 9.537 |
| 63-542-0 |
17«beta»-Hydroxy-4-estren-3-one-methyloxime, trimethylsilyl deriv.
|
124460-92-0 |
2 | 5.782 |
| 63-555-6 |
Imidazolidine-4-thione, 2,2,5,5-tetramethyl-1-nitroso-
|
152450-70-9 |
2 | 1.415 |
| 63-659-1 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androst-1-en-3-one, per-TMS
|
|
2 | 7.761 |
| 63-858-0 |
Silane, diphenylheptyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 5.572 |
| 63-883-2 |
5-«alpha»-Pregnan-3-«beta»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 7.718 |
| 63-923-7 |
1,1,3,3-Tetramethyl-1,3-bis([5-methyl-2-(1-methylethenyl)hex-4-en-1-yl]oxy)disiloxane
|
|
2 | 7.537 |
| 63-949-9 |
(20S)-5«alpha»-cholestan-3«beta»,20,25-triol, DMESI
|
|
2 | 12.446 |
| 63-966-0 |
4,6-Bis([tert-butyl(dimethyl)silyl]oxy)pteridin-2-amine
|
|
2 | 4.770 |
| 63-970-5 |
(20S)-5«alpha»-cholestan-3«beta»,20,25-triol, TMS
|
|
2 | 11.276 |
| 64-046-0 |
Formamide, n-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-n-[4-hydroxy-1-methyl-2-(propyldithio)-1-butenyl]-
|
59-58-5 |
2 | 2.731 |
| 64-082-0 |
6«beta»-Hydroxy-17«alpha»-Methyltestosterone, tris-TMS (2,4-diene)
|
|
2 | 8.735 |
| 64-205-3 |
5«beta»-Pregnane-3«beta», 16«alpha», 20«beta»-triol, MO TMS
|
|
2 | 8.935 |
| 64-215-2 |
3A,21-Dihydroxy-5B-pregnan-11,20-dione, MO TMS
|
|
2 | 7.332 |
| 64-388-1 |
Dodecanoic acid, 9,10-epoxy-12-hydroxy, TMS-ether, OH-TMS
|
|
2 | 5.104 |
| 64-483-5 |
5-«alpha»-Pregnan-3-«alpha»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 7.718 |
| 64-524-9 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3,4-dimethoxy, butylboronate
|
|
2 | 4.976 |
| 64-525-8 |
4-Aminobenzoic acid, N,N-bis(trifluoroacetyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 4.833 |
| 64-557-3 |
P-toluenesulfonamide, alpha-(1,6-dihydro-6-oxo-9h-purin-9-yl)-
|
|
2 | -0.667 |
| 64-578-0 |
trans-Anthracene, 1,2-dihydro-1,2-diol, bis-TMS
|
|
2 | 5.979 |
| 64-640-0 |
17-«beta»-Methyl-5-«beta»-androst-1-ene-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 7.635 |
| 64-653-6 |
17«alpha»-hydroxy-5«alpha»-androstan-3-one (3-enol), per-TMS
|
|
2 | 7.594 |
| 64-669-9 |
5«beta»-Cholestane-3«alpha»,7«alpha»,24R,25-tetrol, TMS
|
|
2 | 11.572 |
| 64-874-1 |
5.alpha.-cholestan-3.beta.,17.alpha.,25-triol, DMESI
|
|
2 | 12.446 |
| 65-032-4 |
5«beta»-Cholestane-3«alpha»,7«alpha»,25-triol, TMS
|
|
2 | 10.742 |
| 65-109-9 |
3«alpha»,6«alpha»,7«alpha»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, trimethylsilyl ether-methyl ester
|
|
2 | 9.945 |
| 65-234-0 |
5-«beta»-Pregnan-3-«alpha»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 7.718 |
| 65-271-9 |
Benzeneacetic acid, 4-[(tert-butyldimethylsilyl)oxy]-3-methoxy-, tert-butyldimethylsilyl ester
|
|
2 | 6.170 |
| 65-397-0 |
Altronic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55528-73-9 |
2 | 4.424 |
| 65-471-7 |
N-(2-Hydroxy-propionyl)-4-methyl-benzenesulfonamide, N,O-di(tert.-butyldimethylsilyl)-
|
|
2 | 5.928 |
| 65-479-9 |
Formamide, n-[4-amino-6-(benzylthio)-5-pyrimidinyl]-n-benzyl-
|
7461-79-2 |
2 | 3.514 |
| 65-584-2 |
Silane, diphenylisobutoxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 5.103 |
| 65-737-2 |
4-Hydroxy-3,4,5,5-tetra-methylthiazolidine-2-thione
|
|
2 | 1.437 |
| 65-759-8 |
3«beta»-Hydroxy-5«alpha»-androstane-7,17-dione, TMS
|
|
2 | 6.774 |
| 65-762-4 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, trimethylsilyl ester
|
|
2 | 4.188 |
| 65-766-0 |
Silane, chlorodiethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)-
|
|
2 | 4.718 |
| 65-769-7 |
Purin-6(1h)-one, 2-chloro-8-chloromethyl-7-methyl-
|
46292-82-4 |
2 | 0.567 |
| 65-894-8 |
5-Pregnen-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 8.856 |
| 65-907-3 |
L-Homoserine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 6.910 |
| 65-966-8 |
5«beta»-Pregnane-3«alpha», 17«alpha»-diol-20-one, MO TMS
|
|
2 | 7.862 |
| 65-989-3 |
16,17-Dihydro-17-OH-GA53 methyl ester TMS ether
|
|
2 | 6.023 |
| 66-060-2 |
trans-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, butylboronate
|
|
2 | 4.531 |
| 66-063-9 |
L-Cystathionine, N,N'-bis(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 9.133 |
| 66-136-8 |
3«beta»,7«alpha»-Dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
2 | 8.424 |
| 66-147-6 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy, 5«alpha»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 10.141 |
| 66-165-6 |
Malonic dilactone, alpha-[2-(morpholino)ethyl]-cis-1(me),3(h),4(h)-cis-3(h)-1,8-dihydroxy-3-p-menthyl
|
|
2 | 1.762 |
| 66-209-7 |
5«alpha»-Pregnane-3«beta», 16«alpha»-diol-20-one, MO TMS
|
|
2 | 7.718 |
| 66-351-9 |
N-[4-(6-methyl)-1,3,3a,7-tetrazaindenyl]-ethylenediamine hydrochloride
|
|
2 | -0.197 |
| 66-352-8 |
1,2,3-Benzotriazine-4-(3h)-one, 6,8-dichloro-
|
60233-65-0 |
2 | 1.143 |
| 66-379-9 |
Butanedioic acid, 2-[(tert-butyldimethylsilyl)oxy]-, bis(tert-butyldimethylsilyl) ester
|
99461-86-6 |
2 | 6.864 |
| 66-474-3 |
6-Azido-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-L-threo-hexono-1,4-lactone
|
|
2 | 3.393 |
| 66-479-8 |
Formamide, n-[4-amino-2,6-bis-(methylthio)-5-pyrimidinyl]-
|
7595-53-1 |
2 | 1.071 |
| 66-521-0 |
[1,2,5]Thiadiazolo[3,4-d]pyrimidine, 5-amino-7-butylamino-
|
|
2 | 1.275 |
| 66-564-3 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 4
|
|
2 | 11.097 |
| 66-565-2 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 1
|
|
2 | 11.097 |
| 66-674-1 |
Allonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-34-9 |
2 | 4.424 |
| 66-675-0 |
Gulonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55528-75-1 |
2 | 4.424 |
| 66-676-9 |
Gluconic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-33-8 |
2 | 4.424 |
| 66-680-4 |
5«beta»-Androstane-3,17-dione,bis-TMS, (2-en)
|
|
2 | 7.720 |
| 66-772-2 |
6'-Galactosyl-lactulose: bD-Galp(1->6)-bDGalp(1->4)-DFru, oxime-TMS, isomer # 1
|
|
2 | 14.361 |
| 66-773-1 |
6'-Galactosyl-lactulose: bD-Galp(1->6)-bDGalp(1->4)-DFru, oxime-TMS, isomer # 2
|
|
2 | 14.361 |
| 66-855-0 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 1
|
|
2 | 6.690 |
| 66-890-1 |
d-Glucose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1E)-
|
130405-10-6 |
2 | 6.351 |
| 66-915-3 |
ent-16«beta»,17-H2(OH)2 6«alpha»,7«alpha»(OH)2 kaurenoic acid, MeTMSi
|
|
2 | 8.674 |
| 67-170-9 |
5.alpha.-Pregnane-11,20-dione-3.alpha.,21-diol, EO-TMS, # 1
|
|
2 | 7.722 |
| 67-172-7 |
5.beta.-Pregnane-11,20-dione-3.alpha.,21-diol, EO-TMS, # 2
|
|
2 | 7.722 |
| 67-238-4 |
6'-Glucosyl-gentobiose: aD-Glcp(1->6)-bDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 67-291-5 |
5«beta»-Androstan-6«beta»-ol-3,17-dione,tris-TMS
|
|
2 | 8.550 |
| 67-385-1 |
5-Cholesten-3-.beta.,7-.alpha.,12-.alpha.,25,26-pentol, TMS
|
|
2 | 12.714 |
| 67-452-6 |
Kojitriose: aD-Glcp(1->2)-aDGlcp(1->2)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 14.359 |
| 67-464-3 |
1,7-Di(2-methylbutyl)-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
2 | 5.250 |
| 67-489-6 |
1,6-Anhydro-2,3-O-isopropylidene-«beta»-D-mannopyranose, trimethylsilyl ether
|
|
2 | 1.482 |
| 67-558-9 |
ent-7«alpha»,16«beta»,17-tri-(OH)-16,17-dihydrokaurenonic acid, Me-TMS
|
|
2 | 7.844 |
| 67-643-4 |
7«alpha»,12«alpha»-dihydroxy, 3-oxy-5«beta»-cholanoate, methyl ester-trimethylsilyl ether
|
|
2 | 9.240 |
| 67-657-9 |
ent-7«alpha»,16«beta»,17-tri-(OH)-16,17-dihydrokaurenolide, Me-TMS
|
|
2 | 7.206 |
| 67-666-9 |
9,10-epoxy-18-hydroxyoctadecanoic acid, TMSi ester TMSi ether
|
|
2 | 7.445 |
| 67-679-5 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TBDMS-16,17-TFA
|
|
2 | 7.493 |
| 67-682-1 |
3«alpha»,6«beta»,7«alpha»,12«beta»-Tetrahydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 9.945 |
| 67-734-3 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 5.840 |
| 67-996-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3-methoxy, methylboronate
|
|
2 | 3.797 |
| 68-130-2 |
Glycine, N-(2-methyl-1-oxo-2-butenyl)-, trimethylsilyl ester, (E)-
|
55517-35-6 |
2 | 1.447 |
| 68-208-6 |
9-Dodecyn-1-ol, dimethyl(dimethyl(pyrid-3-ylmethoxy)silyloxy)silyl ether
|
|
2 | 6.179 |
|
« Previous Results
Next Results »
|